Comparative Pharmacology
Head-to-head clinical analysis: CLOBEX versus CORTONE.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CLOBEX versus CORTONE.
CLOBEX vs CORTONE
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Clobetasol propionate is a corticosteroid with high potency that binds to glucocorticoid receptors, thereby modulating gene expression to inhibit inflammatory mediators (e.g., prostaglandins, leukotrienes) and suppress immune responses. It also induces vasoconstriction and reduces edema.
Cortisone is a corticosteroid that binds to glucocorticoid receptors, leading to decreased inflammation through inhibition of phospholipase A2, reduced cytokine production, and suppression of immune cell migration.
0.05% spray applied to affected area twice daily. Apply twice daily to affected areas of the scalp or body. Do not use more than 2 consecutive weeks or exceed 50 g/week.
Oral: 25-300 mg daily in 1-4 divided doses; typical initial dose 150-300 mg daily. IM/IV: 100-500 mg every 6-12 hours.
None Documented
None Documented
The terminal elimination half-life after topical application is approximately 3.7 hours, consistent with rapid systemic clearance of absorbed drug.
Terminal half-life: 8-12 hours (cortisone) but cortisone is a prodrug; active metabolite cortisol has half-life 1.5-2 hours. Clinical context: duration of action 8-12 hours due to prolonged receptor occupancy.
Primarily renal (minimal biliary/fecal). After topical application, less than 2.5% of the dose is excreted in urine as metabolites.
Renal: ~90% as metabolites (glucuronides and sulfates), ~5% unchanged; biliary/fecal: ~5%.
Category C
Category C
Corticosteroid
Corticosteroid